Page 2

Moderna adjusts IPO target to $521m
AstraZeneca, Merck and Alexion-backed Moderna Therapeutics has set its pricing range at $22 to $24 and would raise more than $521m if it floats at the top end.
Corel to buy Cisco-backed Parallels
Corel will buy the cloud software developer in a deal that would see Ingram Micro and Cisco exit.
Red Hat onboards Noobaa
Data storage business Noobaa, which counts Akamai and OurCrowd among its shareholders, has been acquired by Red Hat.
Movinga locates $17m round
Rocket Internet has returned for a $17m funding round, just over a year after contributing to a $26.4m round, with the money going towards acquisitions of rivals including Move24.
Wuxi NextCode programs $200m series C
Ireland Strategic Investment Fund has led a $200m series C round for Wuxi NextCode after the latter’s acquisition of ISIF and GV-backed Genomics Medicine Ireland.
Enlivex dashes towards Bioblast Pharma
Enlivex Therapeutics is set to conduct a reverse merger with publicly traded Bioblast Pharma, which will be renamed to Enlivex following the transaction.
Tuanche settles on $20m IPO
The Bertelsmann automotive e-commerce platform has priced its shares at the lower end of its range to raise $20m instead of its targeted $150m.
Global Fashion Group changes to IPO mode
The Rocket Internet-founded e-commerce group, whose investors include Tengelmann and Access Industries, could be valued at up to $2.8bn in the offering.
Babytree nurses $217m IPO
Alibaba-backed Babytree priced its shares at the foot of its range and will raise $217m at a valuation of $1.5bn, down from $2.2bn earlier this year.
Tongcheng-eLong books $180m flotation
The travel booking platform, backed by Ctrip, Dalian Wanda and Tencent, has priced shares at the bottom of its range and raised $180m in its initial public offering.

test reg